FUCA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.454600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.638600E-01
Normal-vs-Stage2
4.404600E-01
Normal-vs-Stage3
8.921200E-01
Normal-vs-Stage4
5.992800E-01
Stage1-vs-Stage2
7.951800E-01
Stage1-vs-Stage3
5.034600E-01
Stage1-vs-Stage4
9.942000E-01
Stage2-vs-Stage3
2.677400E-01
Stage2-vs-Stage4
8.229000E-01
Stage3-vs-Stage4
4.163600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.591400E-01
Normal-vs-AfricanAmerican
2.904400E-01
Normal-vs-Asian
6.757600E-01
Caucasian-vs-AfricanAmerican
1.364750E-01
Caucasian-vs-Asian
6.014800E-01
AfricanAmerican-vs-Asian
1.868440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.681200E-01
Normal-vs-Female
4.184800E-01
Male-vs-Female
8.271400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.665800E-01
Normal-vs-Age(41-60Yrs)
3.795800E-01
Normal-vs-Age(61-80Yrs)
5.221400E-01
Normal-vs-Age(81-100Yrs)
2.812800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.868400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.819600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.766000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.476000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.076400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.655600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.835600E-01
Normal-vs-Daily Drinker
9.536200E-01
Normal-vs-Weekly Drinker
3.859800E-01
Normal-vs-Occasional Drinker
4.348600E-01
Normal-vs-Social Drinker
5.084600E-01
Non Drinker-vs-Daily Drinker
2.006600E-01
Non Drinker-vs-Weekly Drinker
2.007600E-01
Non Drinker-vs-Occasional Drinker
2.141600E-01
Non Drinker-vs-Social Drinker
8.245600E-01
Daily Drinker-vs-Weekly Drinker
6.785600E-02
Daily Drinker-vs-Occasional Drinker
6.661600E-02
Daily Drinker-vs-Social Drinker
1.996960E-01
Weekly Drinker-vs-Occasional Drinker
9.250600E-01
Weekly Drinker-vs-Social Drinker
2.535600E-01
Occasional Drinker-vs-Social Drinker
2.745200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.630800E-01
Normal-vs-Grade 2
8.327000E-01
Normal-vs-Grade 3
8.183600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.938200E-01
Grade 1-vs-Grade 3
4.436800E-01
Grade 1-vs-Grade 4
8.630800E-01
Grade 2-vs-Grade 3
6.012600E-01
Grade 2-vs-Grade 4
8.327000E-01
Grade 3-vs-Grade 4
8.183600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.788400E-01
Normal-vs-NonDiabetic
4.594400E-01
Diabetic-vs-NonDiabetic
9.183400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.976400E-01
Normal-vs-NoPancreatitis
4.912400E-01
Pancreatitis-vs-NoPancreatitis
3.407600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.397200E-01
Normal-vs-N1
4.515400E-01
N0-vs-N1
2.675600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.071400E-01
Normal-vs-TP53-NonMutant
5.152800E-01
TP53-Mutant-vs-TP53-NonMutant
9.376800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
